Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 39213-71-3 | MDL No. : | MFCD21234604 |
Formula : | C6H8ClN3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | GABOTYHSSBSAEG-UHFFFAOYSA-N |
M.W : | 157.60 | Pubchem ID : | 298094 |
Synonyms : |
|
Num. heavy atoms : | 10 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.33 |
Num. rotatable bonds : | 0 |
Num. H-bond acceptors : | 2.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 41.38 |
TPSA : | 51.8 Ų |
GI absorption : | High |
BBB permeant : | Yes |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.41 cm/s |
Log Po/w (iLOGP) : | 1.56 |
Log Po/w (XLOGP3) : | 1.2 |
Log Po/w (WLOGP) : | 1.34 |
Log Po/w (MLOGP) : | 0.28 |
Log Po/w (SILICOS-IT) : | 1.69 |
Consensus Log Po/w : | 1.21 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 1.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.02 |
Solubility : | 1.52 mg/ml ; 0.00961 mol/l |
Class : | Soluble |
Log S (Ali) : | -1.88 |
Solubility : | 2.06 mg/ml ; 0.0131 mol/l |
Class : | Very soluble |
Log S (SILICOS-IT) : | -2.67 |
Solubility : | 0.336 mg/ml ; 0.00213 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.22 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 32493-79-1 ]
2,3-Dichloro-5,6-dimethylpyrazine
Similarity: 0.82
[ 1240602-95-2 ]
(6-Chloropyrazin-2-yl)methanol
Similarity: 0.74
[ 72788-94-4 ]
2-Chloro-5-(hydroxymethyl)pyrazine
Similarity: 0.74
[ 1357945-24-4 ]
(6-Chloropyrazin-2-yl)methanamine hydrochloride
Similarity: 0.71
[ 105985-21-5 ]
2-Chloro-5-(chloromethyl)pyrazine
Similarity: 0.71
[ 1357945-24-4 ]
(6-Chloropyrazin-2-yl)methanamine hydrochloride
Similarity: 0.71
[ 21279-64-1 ]
5-Chloropyrazine-2-carboxamide
Similarity: 0.61
[ 113305-94-5 ]
5-Aminopyrazine-2-carbonitrile
Similarity: 0.60
[ 89284-26-4 ]
3-Amino-6-chloropyrazine-2-carbaldehyde
Similarity: 0.60
[ 32493-79-1 ]
2,3-Dichloro-5,6-dimethylpyrazine
Similarity: 0.82
[ 1240602-95-2 ]
(6-Chloropyrazin-2-yl)methanol
Similarity: 0.74
[ 72788-94-4 ]
2-Chloro-5-(hydroxymethyl)pyrazine
Similarity: 0.74
[ 1357945-24-4 ]
(6-Chloropyrazin-2-yl)methanamine hydrochloride
Similarity: 0.71
[ 105985-21-5 ]
2-Chloro-5-(chloromethyl)pyrazine
Similarity: 0.71